-
公开(公告)号:US10201556B2
公开(公告)日:2019-02-12
申请号:US14440826
申请日:2013-11-06
Applicant: InteRNA Technologies B.V.
Inventor: Rick Jan van Haastert , Petronella Innocentia van Noort , Grégoire Pierre André Prevost , Willemijn Maria Gommans , Roeland Quirinus Jozef Schaapveld , Matheus Maria De Gunst , Iman Johannes Schultz , Eugene Berezikov
IPC: C12N15/11 , A61K48/00 , C07H21/02 , C07H21/04 , A61K31/713 , A61K31/4184 , A61K31/437 , A61K31/506 , A61K31/519 , C12N15/113
Abstract: The invention relates to the therapeutic use of a combination in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.
-
2.Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway 审中-公开
Title translation: 用于治疗与黑素瘤相关的疾病或病症或治疗与活化的B-raf途径相关的疾病或病症的组合公开(公告)号:US20150297626A1
公开(公告)日:2015-10-22
申请号:US14440826
申请日:2013-11-06
Applicant: INTERNA TECHNOLOGIES B.V.
Inventor: Rick Jan van Haastert , Petronella Innocentia van Noort , Grégoire Pierre André Prevost , Willemijn Maria Gommans , Roeland Quirinus Jozef Schaapveld , Matheus Maria De Gunst , Iman Johannes Schultz , Eugene Berezikov
IPC: A61K31/713 , A61K31/519 , A61K31/4184 , A61K31/437 , A61K31/506
CPC classification number: A61K31/713 , A61K31/4184 , A61K31/437 , A61K31/506 , A61K31/519 , C12N15/1135 , C12N2310/113 , C12N2310/141 , C12N2320/10 , C12N2320/31 , C12N2330/10 , A61K2300/00
Abstract: The invention relates to the therapeutic use of a combination in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.
Abstract translation: 本发明涉及在与黑素瘤或与活化的BRAF途径相关的疾病或病症相关的疾病和病症中的组合的治疗用途。
-